Archives of Medicine and Health Sciences

REVIEW ARTICLE
Year
: 2022  |  Volume : 10  |  Issue : 1  |  Page : 55--58

Strategies for promoting treatment adherence in schizophrenia


Nagesh B Pai, Shae-Leigh C Vella 
 School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia

Correspondence Address:
Ms. Shae-Leigh C Vella
School of Medicine, University of Wollongong, Wollongong 2522, New South Wales
Australia

Promoting treatment adherence in schizophrenia remains a primary challenge, with nonadherence resulting in a range of challenges across the biological, social, and psychological spectrum. While unknown nonadherence is a central cause of failed psychopharmacological treatment resulting in the initiation of more complex treatment regimens and higher antipsychotic doses, leading to a cycle of further unknown nonadherence and illness exacerbation. This article reviews the importance of treatment adherence including a discussion that can be utilized for promoting treatment adherence in schizophrenia. The following strategies are discussed; the importance of the therapeutic alliance, the use of motivational interviewing, nonpharmacological interventions, pharmacological interventions, and long-acting injectable (LAI) antipsychotics. The article concludes by restating the importance of treatment adherence in schizophrenia and making the patient aware of the consequences of nonadherence. Further, the role of LAI antipsychotics in adherence is highlighted.


How to cite this article:
Pai NB, Vella SLC. Strategies for promoting treatment adherence in schizophrenia.Arch Med Health Sci 2022;10:55-58


How to cite this URL:
Pai NB, Vella SLC. Strategies for promoting treatment adherence in schizophrenia. Arch Med Health Sci [serial online] 2022 [cited 2022 Aug 19 ];10:55-58
Available from: https://www.amhsjournal.org/article.asp?issn=2321-4848;year=2022;volume=10;issue=1;spage=55;epage=58;aulast=Pai;type=0